Search

Displaying results 5781 - 5790 of 7452 in total

Drug
Pam2csk4
go.drugbank.com/drugs/DB16474
Investigational
Categories: Experimental Unapproved Treatments for COVID-19
Drug
Valinomycin
go.drugbank.com/drugs/DB14057
Experimental
It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring.
Categories: Compounds used in a research, industrial, or household setting
Drug
Quisovalimab
go.drugbank.com/drugs/DB16482
Investigational
Categories: Experimental Unapproved Treatments for COVID-19
Drug
Amubarvimab
go.drugbank.com/drugs/DB16493
Investigational
Amubarvimab (BRII-196) was under investigation in clinical trials (NCT04691180 and NCT04787211) to treat COVID-19, focusing on its safety, tolerability, and efficacy.
Categories: Experimental Unapproved Treatments for COVID-19
Drug
Romlusevimab
go.drugbank.com/drugs/DB16494
Investigational
Romlusevimab (BRII-198) was under investigation in clinical trials (NCT04479644 and NCT04691180) to treat COVID-19, focusing on its safety, tolerability, and pharmacokinetics.
Categories: Experimental Unapproved Treatments for COVID-19
Drug
Benzilone
go.drugbank.com/drugs/DB13369
Experimental
Categories: Drugs for Functional Gastrointestinal Disorders
Drug
Quinbolone
go.drugbank.com/drugs/DB13484
Experimental
Categories: Anabolic Agents for Systemic Use
Drug
Fabomotizole
go.drugbank.com/drugs/DB13623
Investigational
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
Drug
Elvucitabine
go.drugbank.com/drugs/DB06236
Investigational
Drug
Iberdomide
go.drugbank.com/drugs/DB12101
Investigational
[L64055,L64056] It is the first cereblon E3 ligase modulator (CELMoD) approved for multiple myeloma.[L64057] … [L64055] The FDA granted iberdomide accelerated approval on August 13, 2026, in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received